Explained: which drugs has Donald Trump been prescribed and why?
Experts say cocktail of medication suggests the president may be seriously ill with Covid

The coronavirus drugs prescribed to Donald Trump indicate that the president may be battling a more severe case of Covid-19 than the White House is letting on, according to infectious disease experts.
After testing positive for coronavirus last week, Trump has been given a powerful cocktail of medications including antiviral drug remdesivir, a steroid called dexamethasone and a combination of antibodies. The 74-year-old’s doctors say he is also taking zinc, vitamin D, famotidine, melatonin and aspirin, but “it is not clear if any of these are deliberately for Covid 19”, the BBC reports.
The combination of drugs given to the president “may never have been prescribed together to an individual patient”, adds the Financial Times. Indeed, the breadth of medicines being taken by Trump has led some experts to suggest that the US leader may be more unwell than his lead physician, Sean Conley, has admitted.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Some experts have raised another possibility: that Trump is directing his own treatment, and is demanding drugs that he does not fully understand.
This phenomenon, says the The New York Times, even has a name: “VIP syndrome, which describes prominent figures who receive poor medical care because doctors are too zealous in treating them - or defer too readily to their instructions”.
“You think you’re helping,” Dr Celine Gounder, a clinical assistant professor of medicine and infectious diseases at the NYU Grossman School of Medicine, told the newspaper. “But this is really a data-free zone, and you just don’t know that.”
Either way, “the use of the experimental treatments will have required a careful weighing of the risks, given the possible side-effects and the chance of adverse interactions between the different chemicals”, says the FT.
Dexamethasone
This steroid works by calming the immune system, but a British professor who led the trial of the drug has said that it works best on serious cases of Covid-19 - “adding to fears over the seriousness of the president’s illness”, The Telegraph reports.
“Dexamethasone reduces mortality or improves survival particularly for patients with severe Covid,” Martin Landray, a professor of medicine and epidemiology at the University of Oxford, told the paper.
Monoclonal antibody therapy
Made by US biotechnology company Regeneron, this combination of antibodies mimics the natural human immune response. There is “huge hope it will be effective”, says the BBC, but “the evidence in patients is still very limited and these monoclonals are still classed as an experimental drug”.
“The president is one of only a handful of people outside those trials to undergo the treatment under what is known as ‘compassionate use’,” the broadcaster adds.
Remdesivir
Developed originally as a treatment for Ebola, remdesivir works by disrupting the ability of the virus to copy itself. Clinical trials have shown the drug can cut the duration of Covid symptoms from 15 days to 11, but it is not a life-saving drug.
And the rest
Vitamin D and zinc both have a role in a healthy immune system, but have never been proven to help fight Covid.
Famotidine decreases stomach acid production and is used for people with stomach ulcers or reflux. Meanwhile, melatonin is a hormone that can improve sleep, while aspirin is a pain killer and blood thinner.
Trials to determine whether aspirin could help fight coronavirus have been launched, but no evidence supporting that hope has emerged.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Arion McNicoll is a freelance writer at The Week Digital and was previously the UK website’s editor. He has also held senior editorial roles at CNN, The Times and The Sunday Times. Along with his writing work, he co-hosts “Today in History with The Retrospectors”, Rethink Audio’s flagship daily podcast, and is a regular panellist (and occasional stand-in host) on “The Week Unwrapped”. He is also a judge for The Publisher Podcast Awards.
-
Why does Donald Trump want Greenland?
The Explainer Trump is not the only US president who has tried to gain control of Greenland
By The Week UK Published
-
What dangers does the leaked Signal chat expose the US to?
TODAY'S BIG QUESTION The White House's ballooning group chat scandal offered a masterclass in what not to say when prying eyes might be watching
By Rafi Schwartz, The Week US Published
-
Trump sets 25% tariffs on auto imports
Speed Read The White House says the move will increase domestic manufacturing. But the steep import taxes could also harm the US auto industry.
By Peter Weber, The Week US Published
-
'Even authoritarian regimes need a measure of public support — the consent of at least some of the governed'
instant opinion 'Opinion, comment and editorials of the day'
By Anya Jaremko-Greenwold, The Week US Published
-
Waltz takes blame for texts amid calls for Hegseth ouster
Speed Read Democrats are calling for Defense Secretary Pete Hegseth and national security adviser Michael Waltz to step down
By Peter Weber, The Week US Published
-
USPS Postmaster General DeJoy steps down
Speed Read Louis DeJoy faced ongoing pressure from the Trump administration as they continue to seek power over the postal system
By Peter Weber, The Week US Published
-
Judge: Nazis treated better than Trump deportees
speed read U.S. District Judge James Boasberg reaffirmed his order barring President Donald Trump from deporting alleged Venezuelan gang members
By Peter Weber, The Week US Published
-
'There is a certain kind of strength in refusing to concede error'
instant opinion 'Opinion, comment and editorials of the day'
By Anya Jaremko-Greenwold, The Week US Published